LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 140 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $56,000 | -57.9% | 10,000 | -50.0% | 0.00% | -100.0% |
Q4 2018 | $133,000 | -37.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $213,000 | -6.6% | 20,000 | +5.3% | 0.00% | 0.0% |
Q2 2018 | $228,000 | +51.0% | 19,000 | +8.0% | 0.00% | 0.0% |
Q1 2018 | $151,000 | -13.2% | 17,600 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $174,000 | -19.4% | 17,600 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $216,000 | -25.5% | 17,600 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $290,000 | +15.1% | 17,600 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $252,000 | +3.7% | 17,600 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $243,000 | -23.6% | 17,600 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $318,000 | +16.1% | 17,600 | -7.9% | 0.00% | 0.0% |
Q2 2016 | $274,000 | +20.2% | 19,100 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $228,000 | -10.2% | 19,100 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $254,000 | +66.0% | 19,100 | +33.7% | 0.00% | +100.0% |
Q3 2015 | $153,000 | +33.0% | 14,285 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $115,000 | – | 14,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $62,009,000 | 100.00% |
Artal Group S.A. | 57,517,977 | $825,383,000 | 17.04% |
NEA Management Company, LLC | 2,382,286 | $34,186,000 | 1.77% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $512,000 | 1.49% |
BRIDGER MANAGEMENT, LLC | 1,029,926 | $14,779,000 | 0.95% |
FALCON POINT CAPITAL, LLC | 287,809 | $4,130,000 | 0.71% |
HANCOCK WHITNEY CORP | 664,025 | $9,529,000 | 0.40% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 494,380 | $7,094,000 | 0.39% |
ELLINGTON MANAGEMENT GROUP LLC | 11,700 | $168,000 | 0.23% |
Convergence Investment Partners, LLC | 114,157 | $1,638,000 | 0.22% |